Blueprint Medicines Corp Stock Price History
| BPMC Stock | USD 128.11 0.04 0.03% |
Below is the normalized historical share price chart for Blueprint Medicines Corp extending back to April 30, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Blueprint Medicines stands at 128.11, as last reported on the 28th of June, with the highest price reaching 128.28 and the lowest price hitting 128.06 during the day.
If you're considering investing in Blueprint Stock, it is important to understand the factors that can impact its price. Blueprint Medicines appears to be very steady, given 3 months investment horizon. Blueprint Medicines Corp secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16 % return per unit of risk over the last 3 months. By analyzing Blueprint Medicines' technical indicators, you can evaluate if the expected return of 0.68% is justified by implied risk. Please makes use of Blueprint Medicines' Risk Adjusted Performance of 0.2154, mean deviation of 2.21, and Downside Deviation of 1.96 to double-check if our risk estimates are consistent with your expectations.
At present, Blueprint Medicines' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. . At present, Blueprint Medicines' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 19.27, whereas Price To Sales Ratio is forecasted to decline to 10.24. Blueprint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of April 2015 | 200 Day MA 96.5844 | 50 Day MA 107.0681 | Beta 0.833 |
Blueprint | Build AI portfolio with Blueprint Stock |
Sharpe Ratio = 0.1609
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BPMC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.21 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.68 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Blueprint Medicines is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Blueprint Medicines by adding it to a well-diversified portfolio.
Price Book 24.1902 | Enterprise Value Ebitda (11.22) | Price Sales 14.7423 | Shares Float 60 M | Wall Street Target Price 130.6 |
Blueprint Medicines Stock Price History Chart
There are several ways to analyze Blueprint Stock price data. The simplest method is using a basic Blueprint candlestick price chart, which shows Blueprint Medicines price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 23, 2025 | 128.4 |
| Lowest Price | April 8, 2025 | 79.22 |
Blueprint Medicines June 28, 2025 Stock Price Synopsis
Various analyses of Blueprint Medicines' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Blueprint Stock. It can be used to describe the percentage change in the price of Blueprint Medicines from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Blueprint Stock.| Blueprint Medicines Price Daily Balance Of Power | (0.18) | |
| Blueprint Medicines Price Action Indicator | (0.08) | |
| Blueprint Medicines Price Rate Of Daily Change | 1.00 | |
| Blueprint Medicines Accumulation Distribution | 5,126 |
Blueprint Medicines June 28, 2025 Stock Price Analysis
Blueprint Stock Price History Data
The price series of Blueprint Medicines for the period between Sun, Mar 30, 2025 and Sat, Jun 28, 2025 has a statistical range of 49.18 with a coefficient of variation of 17.16. The prices are distributed with arithmetic mean of 101.96. The median price for the last 90 days is 99.41.| Open | High | Low | Close | Volume | ||
06/27/2025 | 128.24 | 128.28 | 128.06 | 128.11 | 2,988,770 | |
06/26/2025 | 128.29 | 128.31 | 128.10 | 128.15 | 2,529,566 | |
06/25/2025 | 128.30 | 128.32 | 128.19 | 128.25 | 2,444,676 | |
06/24/2025 | 128.40 | 128.40 | 128.15 | 128.26 | 3,377,048 | |
06/23/2025 | 128.19 | 128.45 | 128.11 | 128.40 | 3,407,460 | |
06/20/2025 | 128.27 | 128.30 | 128.00 | 128.20 | 4,506,151 | |
| 06/18/2025 | 128.29 | 128.32 | 128.02 | 128.12 | 3,540,348 | |
| 06/17/2025 | 128.14 | 128.33 | 128.03 | 128.23 | 3,352,800 | |
06/16/2025 | 128.05 | 128.30 | 127.86 | 128.25 | 5,148,159 | |
06/13/2025 | 128.18 | 128.27 | 127.95 | 127.96 | 4,731,774 | |
| 06/12/2025 | 128.03 | 128.26 | 127.94 | 128.21 | 4,653,922 | |
06/11/2025 | 127.97 | 128.34 | 127.83 | 127.95 | 3,826,825 | |
| 06/10/2025 | 127.95 | 128.10 | 127.75 | 127.97 | 4,462,710 | |
| 06/09/2025 | 127.98 | 127.98 | 127.65 | 127.97 | 7,195,996 | |
06/06/2025 | 128.07 | 128.07 | 127.77 | 127.85 | 3,067,543 | |
06/05/2025 | 128.10 | 128.24 | 127.83 | 127.90 | 4,454,501 | |
| 06/04/2025 | 127.70 | 128.14 | 127.60 | 128.10 | 8,923,089 | |
06/03/2025 | 127.85 | 127.97 | 127.45 | 127.60 | 20,114,926 | |
| 06/02/2025 | 128.01 | 128.15 | 127.43 | 127.79 | 46,416,832 | |
05/30/2025 | 103.17 | 103.17 | 100.57 | 101.35 | 903,308 | |
05/29/2025 | 95.32 | 103.16 | 94.38 | 103.06 | 1,413,002 | |
05/28/2025 | 100.13 | 100.30 | 95.19 | 95.30 | 1,284,598 | |
05/27/2025 | 102.52 | 102.52 | 99.95 | 100.06 | 709,966 | |
05/23/2025 | 99.14 | 101.70 | 98.25 | 101.50 | 353,347 | |
05/22/2025 | 101.00 | 101.75 | 99.65 | 100.34 | 487,838 | |
05/21/2025 | 101.98 | 102.92 | 100.27 | 101.51 | 491,714 | |
05/20/2025 | 100.99 | 103.15 | 96.15 | 103.00 | 448,916 | |
05/19/2025 | 100.80 | 102.45 | 99.29 | 101.22 | 402,415 | |
05/16/2025 | 100.05 | 102.18 | 99.38 | 101.69 | 581,639 | |
05/15/2025 | 97.72 | 100.05 | 97.02 | 99.49 | 444,903 | |
05/14/2025 | 99.46 | 100.38 | 97.49 | 97.51 | 424,300 | |
05/13/2025 | 100.43 | 100.52 | 98.50 | 99.41 | 595,632 | |
05/12/2025 | 97.65 | 101.97 | 97.40 | 100.31 | 717,805 | |
| 05/09/2025 | 100.04 | 101.34 | 97.08 | 97.17 | 621,844 | |
05/08/2025 | 99.13 | 101.17 | 97.91 | 98.76 | 796,704 | |
05/07/2025 | 99.36 | 101.35 | 98.46 | 99.80 | 906,170 | |
05/06/2025 | 100.75 | 103.63 | 99.01 | 99.16 | 1,543,226 | |
05/05/2025 | 104.53 | 104.78 | 100.31 | 101.84 | 1,146,190 | |
05/02/2025 | 99.25 | 104.86 | 98.60 | 104.64 | 1,514,066 | |
05/01/2025 | 91.14 | 99.78 | 90.02 | 99.25 | 1,717,497 | |
04/30/2025 | 88.21 | 89.99 | 87.03 | 89.50 | 1,106,571 | |
04/29/2025 | 88.04 | 89.56 | 87.55 | 88.48 | 573,415 | |
04/28/2025 | 86.34 | 89.19 | 85.70 | 88.51 | 786,733 | |
04/25/2025 | 84.78 | 87.81 | 84.25 | 87.66 | 679,539 | |
04/24/2025 | 86.07 | 86.84 | 84.90 | 86.09 | 762,848 | |
04/23/2025 | 86.02 | 86.85 | 84.38 | 85.81 | 699,038 | |
04/22/2025 | 84.50 | 85.41 | 83.27 | 83.41 | 919,993 | |
04/21/2025 | 84.01 | 86.10 | 83.60 | 84.18 | 934,030 | |
04/17/2025 | 82.16 | 84.97 | 81.19 | 84.69 | 634,400 | |
04/16/2025 | 81.05 | 82.18 | 78.66 | 82.11 | 783,877 | |
04/15/2025 | 81.93 | 83.45 | 79.91 | 81.45 | 1,228,773 | |
04/14/2025 | 82.38 | 83.50 | 79.91 | 82.53 | 775,457 | |
04/11/2025 | 78.50 | 81.28 | 77.63 | 80.84 | 1,646,658 | |
04/10/2025 | 78.48 | 81.86 | 76.84 | 80.27 | 1,274,630 | |
04/09/2025 | 77.49 | 83.54 | 73.04 | 82.05 | 1,903,277 | |
04/08/2025 | 82.09 | 84.66 | 77.36 | 79.22 | 1,308,967 | |
04/07/2025 | 79.00 | 83.91 | 76.50 | 80.20 | 2,034,009 | |
04/04/2025 | 85.51 | 86.00 | 80.08 | 81.68 | 1,492,586 | |
04/03/2025 | 86.36 | 89.14 | 86.21 | 87.11 | 955,994 | |
04/02/2025 | 85.18 | 90.39 | 85.10 | 90.01 | 1,056,340 | |
| 04/01/2025 | 88.51 | 88.67 | 84.55 | 85.94 | 1,434,272 |
About Blueprint Medicines Stock history
Blueprint Medicines investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Blueprint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Blueprint Medicines Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Blueprint Medicines stock prices may prove useful in developing a viable investing in Blueprint Medicines
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 62.9 M | 45.8 M | |
| Net Loss | -501.8 M | -476.7 M |
Blueprint Medicines Quarterly Net Working Capital |
|
Blueprint Medicines Stock Technical Analysis
Blueprint Medicines technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Blueprint Medicines Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Blueprint Medicines' price direction in advance. Along with the technical and fundamental analysis of Blueprint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Blueprint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2154 | |||
| Jensen Alpha | 0.4941 | |||
| Total Risk Alpha | 0.4368 | |||
| Sortino Ratio | 0.2477 | |||
| Treynor Ratio | 0.7459 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Blueprint Stock analysis
When running Blueprint Medicines' price analysis, check to measure Blueprint Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blueprint Medicines is operating at the current time. Most of Blueprint Medicines' value examination focuses on studying past and present price action to predict the probability of Blueprint Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blueprint Medicines' price. Additionally, you may evaluate how the addition of Blueprint Medicines to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |